<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Faas M</submitter><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>European Research Council</funding><funding>Friedrich-Alexander-Universität Erlangen-Nürnberg</funding><pagination>2531-2546.e5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617137</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(11)</volume><pubmed_abstract>Alternatively activated macrophages (AAMs) contribute to the resolution of inflammation and tissue repair. However, molecular pathways that govern their differentiation have remained incompletely understood. Here, we show that uncoupling protein-2-mediated mitochondrial reprogramming and the transcription factor GATA3 specifically controlled the differentiation of pro-resolving AAMs in response to the alarmin IL-33. In macrophages, IL-33 sequentially triggered early expression of pro-inflammatory genes and subsequent differentiation into AAMs. Global analysis of underlying signaling events revealed that IL-33 induced a rapid metabolic rewiring of macrophages that involved uncoupling of the respiratory chain and increased production of the metabolite itaconate, which subsequently triggered </pubmed_abstract><journal>Immunity</journal><pubmed_title>IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation.</pubmed_title><pmcid>PMC7617137</pmcid><funding_grant_id>261193037</funding_grant_id><funding_grant_id>GK1660</funding_grant_id><funding_grant_id>B01/A03</funding_grant_id><funding_grant_id>640087</funding_grant_id><funding_grant_id>FG 2886</funding_grant_id><funding_grant_id>CRC1181-A03/A01/A02/Z2</funding_grant_id><funding_grant_id>810316</funding_grant_id><funding_grant_id>101001866</funding_grant_id><pubmed_authors>Schroder F</pubmed_authors><pubmed_authors>Gruneboom A</pubmed_authors><pubmed_authors>Kirchner P</pubmed_authors><pubmed_authors>Culemann S</pubmed_authors><pubmed_authors>Faas M</pubmed_authors><pubmed_authors>Mougiakakos D</pubmed_authors><pubmed_authors>Kronke G</pubmed_authors><pubmed_authors>Rothe T</pubmed_authors><pubmed_authors>Ipseiz N</pubmed_authors><pubmed_authors>Stoll C</pubmed_authors><pubmed_authors>Schett G</pubmed_authors><pubmed_authors>Wirtz S</pubmed_authors><pubmed_authors>Voehringer D</pubmed_authors><pubmed_authors>Bottcher M</pubmed_authors><pubmed_authors>Kunz M</pubmed_authors><pubmed_authors>Eberhardt M</pubmed_authors><pubmed_authors>Uderhardt S</pubmed_authors><pubmed_authors>Vera J</pubmed_authors><pubmed_authors>Michelucci A</pubmed_authors><pubmed_authors>Ackermann J</pubmed_authors><pubmed_authors>Ekici A</pubmed_authors><pubmed_authors>Fuchs M</pubmed_authors><pubmed_authors>Hofmann J</pubmed_authors><pubmed_authors>Lang R</pubmed_authors><pubmed_authors>Scholtysek C</pubmed_authors><pubmed_authors>Weigmann B</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation.</name><description>Alternatively activated macrophages (AAMs) contribute to the resolution of inflammation and tissue repair. However, molecular pathways that govern their differentiation have remained incompletely understood. Here, we show that uncoupling protein-2-mediated mitochondrial reprogramming and the transcription factor GATA3 specifically controlled the differentiation of pro-resolving AAMs in response to the alarmin IL-33. In macrophages, IL-33 sequentially triggered early expression of pro-inflammatory genes and subsequent differentiation into AAMs. Global analysis of underlying signaling events revealed that IL-33 induced a rapid metabolic rewiring of macrophages that involved uncoupling of the respiratory chain and increased production of the metabolite itaconate, which subsequently triggered </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-06-03T01:09:23.209Z</modification><creation>2025-04-03T23:18:48.067Z</creation></dates><accession>S-EPMC7617137</accession><cross_references><pubmed>34644537</pubmed><doi>10.1016/j.immuni.2021.09.010</doi></cross_references></HashMap>